These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 23712734)

  • 21. Review article: efficacy and safety of rabeprazole in treating gastroesophageal reflux disease.
    Lim PW; Goh KL
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S61-8. PubMed ID: 15324384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
    Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
    Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The impact of proton pump inhibitors on esophageal acid exposure in gastroesophageal reflux disease].
    Liang XY; Chen WN; Lan L; Wang Q; Lü YW; Lan Y
    Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):513-5. PubMed ID: 22943821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.
    Holtmann G; Bigard MA; Malfertheiner P; Pounder R
    Int J Clin Pharm; 2011 Jun; 33(3):493-500. PubMed ID: 21472476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maintenance treatment of mild gastroesophageal reflux disease with proton pump inhibitors taken on-demand: a meta-analysis.
    Jiang YX; Chen Y; Kong X; Tong YL; Xu SC
    Hepatogastroenterology; 2013; 60(125):1077-82. PubMed ID: 23803372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Off-label use of medicines in children: can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
    Tafuri G; Trotta F; Leufkens HG; Martini N; Sagliocca L; Traversa G
    Eur J Clin Pharmacol; 2009 Feb; 65(2):209-16. PubMed ID: 18797857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Esophagitis in children: an update on current pharmacotherapy.
    Shashidhar H; Tolia V
    Expert Opin Pharmacother; 2013 Dec; 14(18):2475-87. PubMed ID: 24138403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esomeprazole: a proton pump inhibitor.
    Vachhani R; Olds G; Velanovich V
    Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):15-27. PubMed ID: 19210109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors.
    Tonini M; Vigneri S; Neri M; Cuomo R; Savarino V; Pace F
    Digestion; 2007; 76(3-4):171-8. PubMed ID: 18046084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
    Johnson DA; Levy BH
    Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical evaluation of proton pump inhibitors in the treatment of gastroesophageal reflux disease.
    Berardi RR
    Am J Manag Care; 2000 May; 6(9 Suppl):S491-505. PubMed ID: 10977489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton pump inhibition. An effective, safe approach to GERD management.
    Berardi RR
    Postgrad Med; 2001 Oct; Spec No():24-35. PubMed ID: 11868428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical considerations in the management of proton-pump inhibitors.
    Aguilera-Castro L; Martín-de-Argila-dePrados C; Albillos-Martínez A
    Rev Esp Enferm Dig; 2016 Mar; 108(3):145-53. PubMed ID: 26666270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on the latest chemical therapies for reflux esophagitis in children.
    Bardou M; Fortinsky KJ; Chapelle N; Luu M; Barkun A
    Expert Opin Pharmacother; 2019 Feb; 20(2):231-239. PubMed ID: 30496693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
    Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
    Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitor therapy and potential long-term harm.
    Corleto VD; Festa S; Di Giulio E; Annibale B
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):3-8. PubMed ID: 24310148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children.
    Dipasquale V; Cicala G; Spina E; Romano C
    Front Pharmacol; 2022; 13():839972. PubMed ID: 35222047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: physician knowledge, patient adherence.
    Solem C; Mody R; Stephens J; Macahilig C; Gao X
    J Am Pharm Assoc (2003); 2014; 54(2):144-53. PubMed ID: 24632930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease.
    Sheikh I; Waghray A; Waghray N; Dong C; Wolfe MM
    Am J Gastroenterol; 2014 Jun; 109(6):789-94. PubMed ID: 24896751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does treatment with proton pump inhibitors for gastroesophageal reflux disease (GERD) improve asthma symptoms in children with asthma and GERD? A systematic review.
    Sopo SM; Radzik D; Calvani M
    J Investig Allergol Clin Immunol; 2009; 19(1):1-5. PubMed ID: 19274922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.